Myovant Sciences Ltd. Deferred Revenue
Myovant Sciences Ltd. had Deferred Revenue of $16.67 million as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2020-11-12
- 2020-09-30: Deferred Revenue $16.67M.
- 2020-06-30: Deferred Revenue $16.67M.
- 2020-03-31: Deferred Revenue $40.00M.
| Period end | Deferred Revenue |
|---|---|
| 2020-09-30 | $16.67M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $16.67M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $40.00M 10-Q · filed 2020-11-12 |